Philip D. Harvey
机构: University of Miami
每年引用次数
引用次数
引用: 64,000
H-指数: 126
I10-指数 : 614
出版物: 1,480
Acquired brain lesions and psychiatric illness : possible role of dopaminergic systems
A. Merriam , T. A. M. Kramer , M. D. Lisoskie , P. Harvey
Mount Sinai Journal of Medicine 58 ( 4) 324 -327
2
1991
Problems associated with applying skills objectives to the discipline of history
G. Wilson , T. Maxwell , P. Harvey
Education research and perspectives 23 ( 2) 70 -94
4
1996
S.18.01 Schizophrenia: Effects of aging on cognition
K Davis , D Stewart , J Friedman , M Buchsbaum
European Neuropsychopharmacology 13
2003
P.3.d.038 Insight into illness and uncooperativeness in chronic schizophrenia
C. Siu , O. Agid , M. Waye , C. Brambilla
European Neuropsychopharmacology 24
2014
P.3.d.065 Evaluation of daytime sleepiness in patients with schizophrenia treated with atypical antipsychotics
A. Loebel , C. Siu , J. Cucchiaro , A. Pikalov
European Neuropsychopharmacology 24
2014
Cognitive enhancement trial with guanfacine in SPD
L.J. Siever , P. Harvey , D. Barch , V. Mitropoulou
Schizophrenia Research 60 ( 1) 315 -316
2003
Two studies of attentional processing in schizotypal personality disorder
V. Mitropoulou , D. Barch , P. Harvey , L. Maldari
Schizophrenia Research 60 ( 1) 148
2003
IMPROVING COGNITIVE AND FUNCTIONAL SKILLS IN OLDER ADULTS WITH SMI
P. Harvey , S.J. Czaja
Innovation in Aging 1 1253 -1253
2017
P.1.j.007 Impact of improved insight in schizophrenia: a double-blind lurasidone and quetiapine XR study
P. Harvey , C.O. Siu , J. Cucchiaro , A. Pikalov
European Neuropsychopharmacology 23
2013
P.1.j.027 Insight into illness and subjective quality-of-life assessment in chronic schizophrenia
C. Siu , O. Agid , M. Waye , C. Brambilla
European Neuropsychopharmacology 23
2013
Neurobiologyy of the schizophrenia spectrum
L.J. Siever , M. Buchsbaum , B. Cornblatt , P. Harvey
European Neuropsychopharmacology 6 99
1996
Severity of comorbid osteoarthritis is not associated with increased risk for incident diabetes mellitus
G.A. Hawker , R. Croxford , A. Bierman , P. Harvey
Osteoarthritis and Cartilage 20
2012
Severity of comorbid osteoarthritis is not associated with increased risk for serious adverse outcomes in individuals with diabetes mellitus
G.A. Hawker , R. Croxford , A. Bierman , P. Harvey
Osteoarthritis and Cartilage 20
2012
Severity of osteoarthritis symptoms and disability predicts risk for serious cardiovascular events
G.A. Hawker , R. Croxford , A. Bierman , P. Harvey
Osteoarthritis and Cartilage 20
2012
P.2.e.003 Factor structure of clinical symptoms in mixed and pure manic episodes: baseline and treatment results
P. Harvey , A. Loebel , L. Warrington
European Neuropsychopharmacology 17
2007
P.3.c.026 Cognitive effects of ziprasidone and clozapine: results from an 18-week double-blind trial
P. Harvey , L. Warrington , A. Loebel , F. Romeo
European Neuropsychopharmacology 17
2
2007
320 – Improvements in everyday functioning with atypical antipsychotic treatment: A randomized long-term comparison of ziprasidone and haloperidol
P. Harvey , C. Kremer , I. Lombardo
Schizophrenia Research 98 165
2008
385 – Cognitive performance in healthy volunteers on a computerized neurocognitive battery
A. Schreiner , M. Kujawa , P. Harvey , R. Bilder
Schizophrenia Research 98 192
2008
EPA-0321 – Impact of improved insight in schizophrenia: a double-blind lurasidone and quetiapine xr study
P. Harvey , C. Siu , J. Cucchiaro , A. Pikalov
European Psychiatry 29 1
2014
POSTER SESSIONS SCHEDULE
L. Lacritz , V. Vargas , N. Upshaw , K. Whigham
Archives of Clinical Neuropsychology 28 ( 6) 518 -626
7
2013